Question 1

What are the main differences between Rasburicase and Allopurinol for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma clinical trial (NCT00199043). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my uric acid levels be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma clinical trial (NCT00199043). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with Rasburicase?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma clinical trial (NCT00199043). Contact the study team or your healthcare provider for specific answers.

Question 4

How does my current treatment plan fit with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma clinical trial (NCT00199043). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific risks for me based on my medical history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma clinical trial (NCT00199043). Contact the study team or your healthcare provider for specific answers.

What this study is about